Ebola,Selective Memory and Educational Costs

Jagadesh S , Sevalie S , Fatoma R . Disability among Ebola survivors and their close contacts in Sierra Leone: a retrospective case-controlled cohort study. Clin Infect Dis 2018; 66: 131–3.

Bah EI , Lamah MC , Fletcher T . Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med 2015; 372: 40–7.

Brett-Major DM . Thinking about Ebola. J R Coll Physicians Edinb 2015; 45: 15–7.

Dye C , Team WHOER . Ebola virus disease in West Africa–the first 9 months. N Engl J Med 2015; 372:189.

De Santis O , Audran R , Pothin E . Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study. Lancet Infect Dis 2016; 16: 311–20.

FIND WHO. Joint WHO/FIND meeting on Diagnostics and Ebola Control. Geneva. 12 December 2014.

Group PIW , Multi-National PIIST , Davey RT Jr . A randomized, controlled trial of ZMapp for Ebola virus infection. N Engl J Med 2016; 375: 1448–56.

Henao-Restrepo AM , Longini IM , Egger M . Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015; 386: 857–66.

Kennedy SB , Bolay F , Kieh M . Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia. N Engl J Med 2017; 377: 1438–47.

OraSure Technologies I. Fact Sheet for Ebola Response Teams: Interpreting Results from the OraQuick® Ebola Rapid Antigen Test for use with Cadaveric Oral Fluid. 2016.

Siegel D , Hui HC , Doerffler E . Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses. J Med Chem 2017; 60: 1648–61.

Lamontagne F , Fowler RA , Adhikari NK . Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet 2018; 391: 700–8.

Brett-Major DM , Jacob ST , Jacquerioz FA . Being ready to treat Ebola virus disease patients. Am J Trop Med Hyg 2015; 92: 233–7.

Nuriddin A , Jalloh MF , Meyer E . Trust, fear, stigma and disruptions: community perceptions and experiences during periods of low but ongoing transmission of Ebola virus disease in Sierra Leone, 2015. BMJ Glob Health 2018; 3: e000410.